Table 1.
Subject | Sex | Age | Body Mass Index | Ethnicity | Cause of Death | Asthma History | Other | Medication(s) | Medication in Hospital | |
---|---|---|---|---|---|---|---|---|---|---|
Subjects with asthma |
||||||||||
1 | M | 72 | 44.2 | W | CVA secondary to ICH | Age of diagnosis unknown | Smoking 16 pack-years, quit 50 YA | Unknown | Unknown | |
2 | F | 34 | 31.93 | W | Anoxia secondary to drug intoxication | Diagnosed 20 YA, hospitalized twice with exacerbations | Inhaler–prednisone | Solu-Medrol, Levophed | ||
3 | M | 29 | 30.8 | W | Anoxia secondary to cardiovascular | Diagnosed 7 YA | Chewing tobacco for 1 yr | Albuterol inhaler | Esmolol, Levophed | |
4 | F | 60 | 25.59 | W | HT secondary to blunt injury |
Diagnosed 10 YA | Complete hysterectomy 40 YA, hypertension | Infrequent inhaler use, hypertension medication | Levophed, Solu-Medrol, phentolamine | |
5 | M | 38 | 29.49 | W | CVA secondary to ICH | Diagnosed at 4 mo | Allergy medications | Norepinephrine, Levophed, phenylephrine, dobutamine | ||
6 | M | 35 | 29.4 | W | Anoxia (asthma) secondary to cardiovascular | Asthma since childhood | Albuterol, Pulmicort | Levophed, Solu-Medrol, albuterol | ||
7 | M | 40 | 26.95 | A | Anoxia secondary to cardiovascular | Asthma diagnosed 5 YA | Dulera | Levophed, Solu-Medrol | ||
8 | F | 38 | 35.78 | W | Anoxia secondary to cardiovascular | Asthma diagnosed at 8 | Singulair | Levophed, epinephrine, dopamine | ||
Control subjects |
||||||||||
9 | M | 22 | 23 | W | HT secondary to SIGSW | Asthma as child, not taken medication in 7 yr | Smoked hookah past year | Albuterol as child and Pepcid | Levophed, Neo-Synephrine, Atrovent, albuterol, Solu-Medrol | |
10 | F | 61 | 35.1 | H | CVA secondary to ICH | Tobacco product 20 YA, diabetes, hypertension | Levophed, albuterol-ipratropium | |||
11 | M | 47 | 26.2 | W | CVA secondary to ICH | Neosynephrine | ||||
12 | F | 55 | 26 | W | CVA secondary to ICH | Alcohol abuse, marijuana and cocaine use | Neosynephrine, dopamine, Levophed, Solu-Medrol, dobutamine | |||
13 | F | 35 | 21.87 | W | Anoxia secondary to ICH | Teenage marijuana use | Levophed | |||
14 | M | 30 | 21.85 | W | Anoxia secondary to asphyxiation | Marijuana, cocaine use | Solu-Medrol | |||
15 | F | 54 | 36.13 | W | CVA secondary to ICH | Smoking 10 pack-years, quit 8 YA | Epinephrine | |||
16 | F | 62 | 30.86 | W | CVA secondary to natural causes | Hypertension, basal cell carcinoma in nose 3 YA | Dopamine | |||
17 | M | 55 | 26.79 | W | HT secondary to blunt injury |
Marijuana occasionally, alcohol abuse | Neosynephrine, Solu-Medrol | |||
18 | F | 58 | 33.87 | W | CVA secondary to ICH | Neosynephrine, Solu-Medrol | ||||
19 | F | 54 | 24.97 | W | HT secondary to blunt injury |
Smoking 30 pack-years, quit 16 YA, hypertension | Levophed, albuterol |
Definition of abbreviations: A = African American; CVA = cerebrovascular accident; H = Hispanic; HT = head trauma; ICH = intracerebral hemorrhage; SIGSW = self-inflicted gunshot wound; W = white; YA = years ago.